ICCT Research International, Inc. ( Site 2211) — Chicago, Illinois

ICCT Research International, Inc. ( Site 2211) is a clinical research site located in Chicago, Illinois, United States 60659.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ICCT Research International, Inc. ( Site 2211) has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ICCT Research International, Inc. ( Site 2211)?

ICCT Research International, Inc. ( Site 2211) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ICCT Research International, Inc. ( Site 2211) conducted?

ICCT Research International, Inc. ( Site 2211) has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is ICCT Research International, Inc. ( Site 2211) accredited by Crixeo Health?

ICCT Research International, Inc. ( Site 2211) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ICCT Research International, Inc. ( Site 2211)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.